Clinical trial
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
NCT02188173 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- May 31, 2016
- Enrollment
- 200 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.